CVS settles controlled-substance and false-claims allegations for $315 million plus interest
CVS executed settlements totaling $315 million in principal, plus interest on the civil settlement, without admitting liability. A related DEA agreement establishes controls for covered CVS retail pharmacies through August 15, 2032. Its operational requirements and implementation clock apply to CVS under the agreement.
Medium priority · Oct 18, 2026 editionRead story →